Print Page  Close Window

SEC Filings

10-K
MYOKARDIA INC filed this Form 10-K on 03/08/2018
Entire Document
 

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

MYOKARDIA, INC.

 

 

 March 8, 2018

By:

 

/s/ T. Anastasios Gianakakos

 

 

 

T. Anastasios Gianakakos

Chief Executive Officer

(Principal Executive Officer and Authorized Signatory)

 

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of T. Anastasios Gianakakos and Jacob Bauer, as his true and lawful attorney-in-fact and agent, with full power of substitution for him, and in his name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and their respective substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ T. Anastasios Gianakakos

 

President, Chief Executive Officer and Director (Principal Executive Officer)

 

March 8, 2018

T. Anastasios Gianakakos

 

 

 

 

 

 

 

 

 

/s/ Jacob Bauer

 

Senior Vice President, Finance and Corporate Development (Principal Financial and Accounting Officer)

 

March 8, 2018

Jacob Bauer

 

 

 

 

 

 

 

 

 

/s/ Sunil Agarwal

 

Director

 

March 8, 2018

Sunil Agarwal, M.D.

 

 

 

 

 

 

 

 

 

/s/ Mary Cranston

 

Director

 

March 8, 2018

Mary B. Cranston

 

 

 

 

 

 

 

 

 

/s/ David P. Meeker

 

Director

 

March 8, 2018

David P. Meeker, M.D.

 

 

 

 

 

 

 

 

 

/s/ Mark L. Perry

 

Director

 

March 8, 2018

Mark L. Perry

 

 

 

 

 

 

 

 

 

/s/ Kimberly Popovits

 

Director

 

March 8, 2018

Kimberly Popovits

 

 

 

 

 

 

 

 

 

/s/ Wendy Yarno

 

Director

 

March 8, 2018

Wendy Yarno